Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
×
Gefitinib
×
Clear all
Filters
3
NCT01203917
2017-01-02
IFUM
AstraZeneca
Phase 4
Completed
1,060 enrolled
14 charts